View Older Stories View More Recent Stories
-
Medline Announces Pricing of Upsized Initial Public Offering
-
Form X-17A-5 RBC CAPITAL MARKETS, For: Oct 31
-
ARC Energy Fund 8 Completes Take-Private Acquisition of STEP Energy Services Ltd.
-
RBC Capital Shares 'Top Investment Ideas for 2026' in Payments, Processing and IT Services
-
Kymera Therapeutics (KYMR) PT Raised to $103 at RBC Capital
-
Ferrari NV (RACE:IM) (RACE) PT Lowered to EUR435 at RBC Capital
-
RBC Capital Resumes International General Insurance Holdings (IGIC) at Outperform
-
RBC Capital Upgrades Jack Henry (JKHY) to Outperform
-
RBC Capital on Zillow Group (ZG): 'Headline negative but fundamental impact less likely'
-
RBC Capital on 2026 North American Diversified Financials Outlook: 'Our Top Ideas Remain BN, EFN, FFH'
-
RBC Capital Shares Thoughts on ServiceNow's (NOW) Reported Talks To Acquire Armis
-
RBC Capital on General Mills (GIS): 'Progress Towards a Recovery Should Be Rewarded'
-
RBC Capital on CarMax (KMX): 'A Lot of Questions Should Be Answered Following Guide Down'
-
Altus Group Announces Exemptive Relief from the Ontario Securities Commission in connection with its Substantial Issuer Bid
-
Abeona Therapeutics names Mohamad Tabrizi as chief business officer
-
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
-
Baytex sets December 19 closing date for Eagle Ford sale
-
Baytex Announces Expected Closing Date for U.S. Eagle Ford Sale and Early Results of Cash Tender Offer for 2032 Senior Notes
-
RBC Capital Reinstates Energy Transfer (ET) at Outperform
-
RBC Capital Downgrades Smith & Nephew PLC. (SN:LN) (SNN) to Sector Perform
-
RBC Capital Starts Telix Pharmaceuticals Ltd (TLX:AU) at Sector Perform
-
Netskope (NTSK) PT Raised to $27 at RBC Capital
-
Applied Therapeutics (APLT) PT Lowered to $0.25 at RBC Capital
-
Linde (LIN) PT Lowered to $490 at RBC Capital
-
Southern Co. (SO) PT Lowered to $99 at RBC Capital
-
RBC Capital Reiterates Outperform Rating on Uber Inc. (UBER)
-
Contineum Therapeutics prices $90 million public offering at $12.25 per share
-
Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering
-
Legence prices upsized secondary offering at $45 per share
-
Wealthfront Announces Pricing of Initial Public Offering
-
Legence Announces Pricing of Upsized Secondary Underwritten Public Offering of Class A Common Stock
-
WSFS Financial completes $200 million senior notes offering
-
WSFS Financial Corporation Announces Completion of Senior Unsecured Notes Offering
-
Contineum Therapeutics announces $75 million public offering
-
Contineum Therapeutics Announces Proposed $75.0 Million Public Offering
-
Oracle (ORCL) PT Lowered to $250 at RBC Capital
-
Johnson & Johnson (JNJ) PT Raised to $230; RBC Capital: 'We See Upside'
-
Boats Group Announces Investment from General Atlantic and CPP Investments
-
Gold Royalty completes $103.5 million public offering
-
Gold Royalty Completes US$103.5 Million Bought Deal Financing
-
RBC Capital Reiterates Sector Perform Rating on Incyte (INCY)
-
Arrowhead Pharma (ARWR) PT Raised to $80 at RBC Capital
-
RBC Capital Reiterates Outperform Rating on Chewy Inc. (CHWY)
-
RBC Capital Reiterates Outperform Rating on Verisk Analytics (VRSK)
-
RBC Capital Reiterates Outperform Rating on Adobe (ADBE)
-
RBC Capital Upgrades Aker BP (AKRBP:NO) (DETNF) to Outperform
-
Graphic Packaging Holding Company (GPK) PT Lowered to $15 at RBC Capital
-
GE Vernova hits record high on bullish 2026 revenue outlook, buyback boost
-
Brompton Split Banc Corp. Completes Preferred Share Offering
-
'Bombardier (BBB/B:CN) (BDRBF) Still a Compelling Opportunity'; PT Raised at RBC Capital
